Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 522,220 shares at $14.50 ($7.6M) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Scheduled sale ($7.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.50 | 144,444 | $2.1M | 27.6% |
| 2 | $14.56 | 188,888 | $2.8M | 36.2% |
| 3 | $14.56 | 188,888 | $2.8M | 36.2% |
| Total | $14.54 avg | 522,220 | $7.6M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |